Pfizer said it would buy Anacor Pharmaceuticals in an all-cash deal worth about $4.5 billion, as it turns to smaller deals after walking away from its scuttled acquisition of Allergan PLC.
from WSJ.com: US Business http://ift.tt/1OvBj5q
via IFTTT
No comments:
Post a Comment